Endocan Corp Company Executives
| ENDO Stock | USD 0.0001 0.00 0.00% |
Endocan Corp employs about 31 people. The company is managed by 9 executives with a total tenure of roughly 16 years, averaging almost 1.0 years of service per executive, having 3.44 employees per reported executive. Analysis of Endocan Corp's management performance can provide insight into the firm performance.
| Robert Kane CEO CEO and President Acting CFO and Director |
| Mario Lap President President of European Operations and Director |
Endocan |
Endocan Corp Management Team Effectiveness
Endocan Corp's management efficiency ratios could be used to measure how well Endocan Corp manages its routine affairs as well as how well it operates its assets and liabilities.Endocan Corp Workforce Comparison
Endocan Corp is one of the top stocks in number of employees category among its peers. The total workforce of Specialty Chemicals industry is currently estimated at about 149. Endocan Corp totals roughly 31.0 in number of employees claiming about 21% of equities listed under Specialty Chemicals industry.
Endocan Corp Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Endocan Corp Price Series Summation is a cross summation of Endocan Corp price series and its benchmark/peer.
Endocan Corp Notable Stakeholders
An Endocan Corp stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Endocan Corp often face trade-offs trying to please all of them. Endocan Corp's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Endocan Corp's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Robert Kane | CEO and President Acting CFO and Director | Profile | |
| Mario Lap | President of European Operations and Director | Profile | |
| Alfredo DupetitBernardi | VP Director | Profile | |
| Graciela Moreno | VP Director | Profile | |
| Raymond Dabney | Pres CEO | Profile | |
| Wayne Howey | Head Services | Profile | |
| C Tam | S Treasurer | Profile | |
| Steven Garrett | Chief Key | Profile | |
| Anthony Spring | Head Director | Profile |
About Endocan Corp Management Performance
The success or failure of an entity such as Endocan Corp often depends on how effective the management is. Endocan Corp management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Endocan management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Endocan management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Thermic Sciences International develops and sells hemp based products. Thermic Sciences International was incorporated in 1969 and is based in Colorado Springs, Colorado. ENDOCAN CORP operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange.
Endocan Corp Workforce Analysis
Traditionally, organizations such as Endocan Corp use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Endocan Corp within its industry.Endocan Corp Manpower Efficiency
Return on Endocan Corp Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 106.8K | |
| Net Loss Per Executive | 367.9K |
Other Information on Investing in Endocan Pink Sheet
Endocan Corp financial ratios help investors to determine whether Endocan Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Endocan with respect to the benefits of owning Endocan Corp security.